[SCHEDULE 13G/A] Molina Healthcare, Inc. SEC Filing

Rhea-AI Filing Summary

Capital Research Global Investors (CRGI) discloses beneficial ownership of 2,166,093 shares of Molina Healthcare common stock, representing 4.0% of 54,200,000 shares believed outstanding. CRGI reports sole voting power over 2,161,524 shares and sole dispositive power over 2,166,093 shares, and identifies itself as an investment adviser organized in Delaware filing under Rule 13d-1(b).

The filing states the position is held in the ordinary course of business and was not acquired to change or influence control of the issuer. Because the stake is under 5%, it is reported on Schedule 13G/A as a passive institutional holding, which signals notable institutional interest without indicating an active control campaign.

Insights

Securities Analyst

TL;DR: Institutional passive stake of 4.0% is material for disclosure but neutral on control or governance.

CRGI's reported 2,166,093-share holding equates to 4.0% of the company and includes near-total sole voting and dispositive authority over those shares. As this is a Schedule 13G/A filing under Rule 13d-1(b), the position is presented as passive and held in the ordinary course of business. For investors, this represents meaningful institutional interest that may support share liquidity and market confidence, but it does not signal an activist intent or shift in corporate control based on the filing alone.

Corporate Governance Expert

TL;DR: Disclosure documents a sizable institutional stake but affirms no intent to influence control.

The filing shows CRGI has sole voting power on 2,161,524 shares and sole dispositive power on 2,166,093 shares. The certification explicitly states shares were acquired and are held in the ordinary course of business and not for the purpose of changing control. From a governance perspective, this is a passive ownership disclosure: important for transparency and for monitoring institutional ownership trends, but not a governance action such as a 13D activist filing.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

Molina Healthcare, Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

60855R100

(CUSIP Number)

06/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 60855R100

1

Names of Reporting Persons

Capital Research Global Investors

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 2,161,524.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 2,166,093.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,166,093.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.0 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Molina Healthcare, Inc.
(b)	Address of issuer's principal executive offices: 200 Oceangate, Suite 100, Long Beach, CA 90802
Item 2.
(a)	Name of person filing: Capital Research Global Investors
(b)	Address or principal business office or, if none, residence: 333 South Hope Street, 55th Fl, Los Angeles, CA 90071
(c)	Citizenship: N/A
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 60855R100
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 2,166,093 ** **Capital Research Global Investors ("CRGI") is a division of Capital Research and Management Company ("CRMC"), as well as its investment management subsidiaries and affiliates Capital Bank and Trust Company, Capital International, Inc., Capital International Limited, Capital International Sarl, Capital International K.K., Capital Group Private Client Services, Inc., and Capital Group Investment Management Private Limited (together with CRMC, the "investment management entities"). CRGI's divisions of each of the investment management entities collectively provide investment management services under the name "Capital Research Global Investors." CRGI is deemed to be the beneficial owner of 2,166,093 shares or 4.0% of the 54,200,000 shares believed to be outstanding.
(b)	Percent of class: 4.0 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 2,161,524
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 2,166,093
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Capital Research Global Investors

Signature:	Jae Won Chung
Name/Title:	Vice President and Senior Counsel II, Capital Research and Management Company
Date:	08/05/2025

FAQ

How many Molina Healthcare (MOH) shares does Capital Research Global Investors hold?

Capital Research Global Investors beneficially owns 2,166,093 shares of Molina Healthcare common stock.

What percentage of MOH does CRGI's position represent?

The position represents 4.0% of the 54,200,000 shares believed to be outstanding.

Does CRGI have voting power over the MOH shares it reports?

Yes. CRGI reports sole voting power over 2,161,524 shares and sole dispositive power over 2,166,093 shares.

Is this filing an active attempt to change control at Molina Healthcare?

No. The filing certifies the securities are held in the ordinary course of business and were not acquired to change or influence control, consistent with a Schedule 13G/A passive disclosure.

Under which rule was the Schedule 13G/A filed?

The filing is made under Rule 13d-1(b) as an investment adviser (IA) reporting a passive position.